Page 3 - பிரமல் நிறுவனங்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Piramal Enterprises looking at acquisition of multiple pharma assets, possible re-entry into domestic formulations Moneycontrol 13 hours ago Viswanath Pilla © Viswanath Pilla Piramal Enterprises looking at acquisition of multiple pharma assets, possible re-entry into domestic formulations Piramal Enterprises Ltd (PEL) is looking at multiple acquisition opportunities across its pharma business, including a possible re-entry into domestic formulations, which the company exited in 2010. The company, in its FY21 annual report, said that it is looking at acquisitions of niche manufacturing capabilities for a Contract Development and Manufacturing Organisation (CDMO). A CDMO is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development to manufacturing.

United statesPiramal pharmaAjay piramalManufacturing organisationContract developmentNavin fluorine internationalViswanath pilla piramal enterprisesPiramal enterprises ltdPiramal enterprisesCarlyle groupEnterprises ltdAllergan indiaConvergence chemicalsHemmo pharmaceuticalsஒன்றுபட்டது மாநிலங்களில்பிரமல் பார்மா